Colorado biotech Ambrosia lands $100M for oral GLP-1news2026-03-31T15:40:15+00:00March 31st, 2026|Endpoints News|
Kailera plans IPO for Phase 3 obesity drug from Hengruinews2026-03-29T23:05:55+00:00March 29th, 2026|Endpoints News|
Oral peptides biotech Pinnacle Medicines gets $89M from US, China investorsnews2026-03-26T11:30:18+00:00March 26th, 2026|Endpoints News|
Microneedle vaccine patch company raises $50M for pivot to GLP-1 deliverynews2026-03-25T13:00:28+00:00March 25th, 2026|Endpoints News|
Gilgamesh’s psychedelics pipeline gets $60M backing after AbbVie dealnews2026-03-25T10:00:55+00:00March 25th, 2026|Endpoints News|
Q&A: Controversial embryo editing entrepreneur Cathy Tie on her new startupnews2026-03-24T14:10:54+00:00March 24th, 2026|Endpoints News|
XO Health to expand its alternative health plan nationwidenews2026-03-24T13:00:57+00:00March 24th, 2026|Endpoints News|
Sanofi extends $180M to California T cell engager startup Kalinews2026-03-23T11:00:42+00:00March 23rd, 2026|Endpoints News|
Verily raises $300M, sheds Alphabet’s majority controlnews2026-03-19T18:00:37+00:00March 19th, 2026|Endpoints News|
Washington’s Medicaid program will pay for ElliQ, an AI robot for lonelinessnews2026-03-19T13:00:43+00:00March 19th, 2026|Endpoints News|
